| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Nautilus Biotechnology, Inc. | 10%+ Owner | Common Stock | 16,298,006 | $33,081,693 | $2.03 | 09 Jun 2021 | By AH Bio Fund II, L.P. |
| Nautilus Biotechnology, Inc. | 10%+ Owner | Common Stock | 1,355,911 | $2,752,228 | $2.03 | 09 Jun 2021 | By Andreessen Horowitz LSV Fund II, L.P. |
| EQRx, Inc. | 10%+ Owner | Common Stock | 0 | $2.21 | 09 Nov 2023 | By AD Holdings, LLC | |
| EQRx, Inc. | 10%+ Owner | Common Stock | 0 | $2.21 | 09 Nov 2023 | By AH Bio Fund III, L.P. | |
| EQRx, Inc. | 10%+ Owner | Common Stock | 0 | $2.21 | 09 Nov 2023 | By AH Bio Fund II, L.P. | |
| EQRx, Inc. | 10%+ Owner | Common Stock | 0 | $2.21 | 09 Nov 2023 | By Andreessen Horowitz LSV Fund II, L.P. | |
| EQRx, Inc. | 10%+ Owner | Common Stock | 0 | $2.21 | 09 Nov 2023 | By Andreessen Horowitz LSV Fund I, L.P. | |
| EQRx, Inc. | 10%+ Owner | Earn-out Shares | 0 | 09 Nov 2023 | By AH Bio Fund III, L.P. | ||
| EQRx, Inc. | 10%+ Owner | Earn-out Shares | 0 | 09 Nov 2023 | By AH Bio Fund II, L.P. | ||
| EQRx, Inc. | 10%+ Owner | Earn-out Shares | 0 | 09 Nov 2023 | By Andreessen Horowitz LSV Fund I, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924323020289-ah-equity-partners-bio-ii-l-l-c-2023-11-09 | EQRx, Inc. | 09 Nov 2023 | 8 | $0 | 4 | 10%+ Owner | 09 Nov 2023, 16:05 |
| /report/000110465923001125-ah-equity-partners-bio-ii-l-l-c-2023-01-01 | EQRx, Inc. | 01 Jan 2023 | 3 | $0 | 4 | 10%+ Owner | 04 Jan 2023, 20:59 |
| /report/000089924321049472-ah-equity-partners-bio-ii-l-l-c-2021-12-17 | EQRx, Inc. | 17 Dec 2021 | 0 | $0 | 3 | 10%+ Owner | 22 Dec 2021, 20:05 |
| NAUT | Nautilus Biotechnology, Inc. | 09 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 09 Jun 2021, 21:40 |